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Adenosine is a candidate modulator of sperm motility in the
female reproductive tract that increases sperm flagellar beat fre-
quency in vitro. Past work suggested that this acceleration may
involve equilibrative (ENT) and concentrative (CNT) nucleo-
side transporters. Here we show that Slc29a1 (ENT-1) is the
predominant nucleoside transporter expressed in the mouse
testis. Unexpectedly, the beat of Slc29a1-null sperm still accel-
erates in response to 2-chloro-2-deoxyadenosine (Cl-dAdo).
Moreover, in wild-type sperm neither blockade of CNTs by
removal of external Na, nor inhibition of ENTs with nitroben-
zylthioionosine, prevents acceleration of the sperm beat by
Cl-dAdo. In contrast, pertussis toxin produces strong block-
ade, indicating involvement of a Gi/o-coupled adenosine
receptor. Although agonists selective for adenosine receptors
A1R, A2aR, and A2bR are ineffective, A3R-selective agonists
Cl-IB-MECA and IB-MECA do accelerate the beat. Consis-
tent with this pharmacological profile, the predominant
Adora transcripts in the testis are products of the nested
Adora3i1 and Adora3i2 genes. Surprisingly, Cl-IB-MECA
and Cl-dAdo still accelerate the beat of Adora3i1-null sperm
indicating that the remaining Adora3i2 transcript produces
an A3R that functions in sperm. When cloned Adora3i2 is
heterologously expressed in tsA-201 cells, Cl-dAdo decreases
forskolin-evoked accumulation of cAMP, indicating that
Adora3i2 specifies a functional A3Ri2 adenosine receptor
that couples through Gi. Database mining reveals that
mouse Adora3i2 is expressed primarily in testis, almost
exclusively in spermatids. Expression of the orthologous
ADORA3i3 transcript also is most prominent in human tes-
tis; presumably producing an A3Ri3 receptor that is func-
tional in sperm and that may be a target for development of
male-directed contraceptives.
The only known roles of sperm are to reach the egg and
deliver its genetic payload and to initiate early signaling events
in the zygote. Although the list is short, the tasks are complex,
and the sperm requires numerous specialized components to
accomplish these goals. Our recent work has focused on how
the sperm applies its specialized components to control swim-
ming behavior. We have combined biophysical methods with a
genetic approach, using sperm from null-mutant (knock-out)
mice that carry targeted disruptions of the genes for several of
the components of the signaling pathways that operate in the
sperm flagellum. This approach has provided definitive evi-
dence for required roles of the unique CatSper ion channel
proteins (1–7), for the atypical sperm adenylyl cyclase SACY2
(3, 8), and for the sperm-specific C2 catalytic subunit of PKA
(9, 10). It also produced the unexpected finding that adenosine
analogs engage cAMP-mediated signaling to increase flagellar
beat frequency (10, 11).
In some somatic cells, adenosine activates cell surfaceG-pro-
tein-coupled adenosine receptors that couple to various con-
ventional transmembrane adenylyl cyclases (ADCY1–9) to
control synthesis of cAMP (12, 13). However, in sperm the pre-
dominant (perhaps the only) adenylyl cyclase is the atypical
SACY (ADCY10) (8), which lacks transmembrane domains and
is unaffected by G-proteins (14, 15). The apparent absence of
conventional adenylyl cyclases led us to propose that adenosine
analogs may enter sperm via cell surface nucleoside transport-
ers to engage the SACY/PKA signaling pathway (10, 11). We
now reconsider this proposal, evaluating the expression of
Slc28a and Slc29a nucleoside transporters in adult mouse tes-
tis, and examining the phenotype of sperm from the Slc29a1
knock-out mouse (16).
Some other past work reports finding adenosine receptor
binding activity and immunoreactivity in sperm (17–20). We
now also reexamine the expression of adenosine receptor genes
in the testis and spermatogenic cells and explore the sperm
phenotype of the Adora3 knock-out mouse (21). The results
provide new insights about the nature of the Adora3i2 tran-
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script in testis and of expression of A3R adenosine receptors in
mouse sperm and of the orthologous ADORA3i3 transcript in
human testis that presumably generates A3Rs for human
sperm.
EXPERIMENTAL PROCEDURES
Materials—The cAMP radioimmunoassay kit NEK 033
was from Perkin-Elmer (Shelton, CT). CGS21680, CCPA, IB-
MECA, and Cl-IB-MECA were from Calbiochem. Pertussis
toxin B-oligomer was from List (Campbell, CA) and tagRFP
vector was a generous gift from Dr. Roger Tsien (UCSD, San
Diego, CA). Protease Inhibitor Mixture, pertussis toxin, and
2-chloro-2-deoxyadenosine (Cl-dAdo) and all other chemicals
were from Sigma-Aldrich, unless indicated otherwise.
Sperm Preparation and Incubation—Sperm were prepared
as in prior work (1, 2, 22, 23) Briefly, after euthanasia by CO2
asphyxiation, caudae epididymides, and vasa deferentia were
excised from male mice, either wild-type retired breeders of
CD1 or Swiss-Webster strains, or from adult male Adora3/
(21) or Slc29a1/ (16) knock-out strains of known fertility and
from age-matched wild-type animals of the same genetic back-
grounds. Slc29a1/ breeding pairs were maintained in a hy-
brid (50% C57BL6/J, 50% SX1/SvJ) background. Adora3i1/
breeding pairs were maintained in a C57BL6/J background.
After rinsing with medium HS (in mM): 135 NaCl, 5 KCl, 2
CaCl2, 1 MgSO4, 20 HEPES, 5 glucose, 10 lactic acid, 1 pyruvic
acid, adjusted to pH 7.4 with NaOH, the excised tissue was
transferred to 1ml of a swimout/capacitationmedium (HSwith
5 mg BSA/ml and 15 mM NaHCO3). Semen was allowed to
exude (15 min at 37 °C, 5% CO2) from several small incisions.
All subsequent operations were at room temperature (22–
25 °C) in medium HS, unless noted otherwise. Sperm were
washed twice, then dispersed, and stored at 1–2 107 cells
ml1. Some experiments used Na-deficient versions of me-
dium HS prepared by replacement of NaCl with N-methyl-D-
glucamine hydrochloride and of NaHCO3 with tetraethylam-
monium bicarbonate.
Adenosine Analogs, Pharmacological Agonists, and Trans-
port Inhibitors—Stock solutions of Cl-dAdo (1 mM in medium
HS) and other adenosine analogs, agonists, and inhibitors
(1–30mM inDMSO)were stored frozen. After final dilution the
DMSOwas 1% (v/v). A parallel solvent-only control was per-
formed when addition of stocks produced DMSO 0.1%.
RNA Extraction and Gene Expression—Mouse tissue was
rapidly frozen in liquid nitrogen, transferred to 6 M guani-
dinium chloride and sonicated. Mouse testis RNA was isolated
using the RNAeasyTM kit (Qiagen, Germantown, MD) per the
manufacturer’s instructions. Human testis RNAwas purchased
from Origene (Rockville, MD). RNA concentrations were
determined from A260. Quantitative RT-PCR reactions were
performed using 25 ng of RNA in Brilliant II Syber GreenMas-
ter MixTM with reverse transcriptase (Stratagene, La Jolla, CA)
using gene-specific primers with matched annealing tempera-
tures and similar amplicon lengths. Mouse primers: Slc29a1
(F: 5-CAGCCTGTGCAGTTGTCATT-3, R: 5-CCGTGAA-
GATGAAGCAGACA-3), Slc29a2 (F: 5-TTGCCCGTTACT-
ACCTGACC-3, R: 5-CGACAGGGTGACTGTGAAGA-3),
Slc29a3 (F: 5-TAGCAGCTCCTCCACCATCT-3, R: 5-GGC-
AACTGGCCTCATGTAGT-3), Slc29a4 (F: 5- ACCGCTA-
CCATGCCATCTAC-3, R: 5-CCTGGTCGTGAGAGAAG-
AGC-3), Slc28a1 (F: 5-TGGTCTACCCAGAGGTGGAG-3,
R: 5-GGACGTAGGAGCAGATGAGC-3), Slc28a2 (F: 5-
ATGCTTGAAGCCTCTGGAAA-3, R: 5-ATCTGATCTCC-
CAGCCATTG-3), Slc28a3 (F: 5-CAAACTGGGCCAACAA-
AACT-3, R: 5-GGGCAGGATCTTAAATGCAA-3),Adora1
(F: 5-CTTCTACCTGATCCGCAAGC-3, R: 5-AGAAAGG-
TGACCCGGAACTT-3), Adora2a (F: 5-GGCTCCTCGGT-
GTACATCAT-3, R: 5-GGCTGAAGATGGAACTCTGC-
3), Adora2b (F: 5-CCTTTGGCATTGGATTGACT-3, R: 5-
CCTGGAGTGGTCCATCAGTT-3), Adora3i1(F: 5-CCCT-
GGTTGTCATGTGTGTC-3, R: 5-AGGGTTCATCATGG-
AGTTCG-3), Adora3i2 (F: 5-CAGGTGTTGAGCTGGAG-
ACA-3, R: 5-ATTGGCCCGGTCTTCTCTAT-3). Human
primers: ADORA3i1 (F: 5-GGGCATCACAATCCACTTCT-
3, R: 5-CATGACCATGGCATCTGAAA-3), ADORA3i2 (F:
5-TTGTCATGTGCGCCATCTAT-3, R: 5-AGGGTTCAT-
CATGGAGTTGG-3), ADORA3i3 (F: 5-GACCCATTGAG-
CAGAAGGAG-3, R: 5-CACATGACTGGAAGGAAGCA-
3). Quantitative PCR was performed in a MX3000P PCR
machine (Stratagene), and the productswere verified for appro-
priate length by gel electrophoresis then sequenced. Relative
gene expression was determined using the Ct method with
normalization to Arbp (acidic ribosomal-binding protein) as in
Sanz et al. (24). Positive control reference tissues were used to
verify primer efficacy. RNA for human and mouse was also
reverse-transcribed to generate cDNA using the Superscript
First Strand Synthesis System (Invitrogen, Carlsbad CA). Full-
length transcripts were amplified using transcript-specific
primer combinations: human ADORA3i2 (F: 5-ATGCCC-
AACAACAGCACTG-3, R: 5-CTACTCAGAATTCTTCT-
CAATGCTTG-3); ADORA3i3 (F: 5-ATGGAAGGGTCT-
CCAGCAG-3, R: 5-TCACATCTGTTCAGTAGGAGCC-
3). Full-length mouse transcripts of Adora3i1 and Adora3i2
were amplified with the primers used for cloning (see below).
Transcripts of Adora3i3, which shares exons with both
Adora3i1 and Adora3i2, were probed with the Adora3i2 for-
ward primer and the Adora3i1 reverse primer. PCR products
were visualized on 1% agarose gels run in TAE (Tris-acetate-
EDTA) buffer and stained with ethidium bromide.
Protein Extraction—Tissues and sperm were extracted with
the TNE buffer (10 mM Tris pH 8.0, 1 mM EDTA, 0.5% Nonidet
P-40, 1 protease inhibitor mixture) for 45 min on ice with
vortexing every 5min. Samples were clarified by centrifugation
(10000  g, 5 min), and protein concentration was determined
using the BCA protein assay reagent (Thermo Scientific).
Videomicroscopy and Waveform Analysis—As in past work
(22), time series of stop-motion, phase-contrast images of
loosely-tethered spermwere recorded while a gravity-fed, sole-
noid-controlled local-perfusion device applied and removed
test solutions. After adjustments of image size and orientation
using Metamorph (Molecular Devices, Toronto, Canada) and
Igor Pro (Wavemetrics, LakeOswego,OR) the flagellar location
in each image was captured by automated determination of
intensity maxima and minima in a line-scan perpendicular to
the axis of the flagellar beat. The most prominent peak in the
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power spectrum of the Fourier transform of the flagellar loca-
tion over time then directly reported flagellar beat frequency.
Cloning and Recombinant Protein Expression—Cloning of
Adora3i2 was performed by RT-PCR amplification of the full-
length transcript from testis RNA using gene-specific primers
(Forward: 5-TATCGAAGCTTCGCCACCATGGAGTTCC-
TCCTCCTTCTCT-3, Reverse: 5-GATACGGATCCCCTC-
AAATCCTTGCCAAAGTTATG-3) as described (6). EcoRI
andHindIII restriction sites were incorporated into the 5-ends
of the forward and reverse PCR primers (underlined), to facili-
tate cloning into the EcoRI and HindIII sites in the tagRFP
vector. A consensus Kozak sequence, CGCCAAC, was inserted
upstream of the Adora3i2 start codon to ensure efficient trans-
lation. The full-length, PCR-amplified template was then
digested with EcoRI and HindIII and ligated into the tagRFP
vector. The ligated plasmids were then transformed into chem-
ically competent DH5 Escherichia coli. Plasmid DNA isolated
from bacterial clones was fully sequenced to verify the identity
of the inserted gene. Recombinant adenosine receptor
Adora3i2was expressed in tsA-201 cells in culture by transient
transfection with Fugene 6 (Roche, Mannheim, Germany),
according to themanufacturer’s instructions. Cells were grown
inDMEMcontaining 10% (v/v) fetal bovine serumand 1% (w/v)
penicillin/streptomycin at 37 °C. Cells were transfected at 50%
confluency and assayed at 100% confluency 24–36 h after
transfection. Control cells were transfected with cytosolic GFP
(Invitrogen).
Cell Treatments and cAMP Radioimmunoassay—Trans-
fected cells were washed with and equilibrated for 15 min in
assay buffer (in mM): 110 NaCl, 5 NaHCO3, 1.2 NaH2PO4, 5
KCl, 2.7 CaCl2, 1MgSO4, 20HEPES, 10 glucose, adjusted to pH
7.4 with NaOH. Incubation continued for 15 min in the pres-
ence of 1mM IBMX. Triplicate wells were further treated for 15
min with the same buffer containing 1 mM IBMX alone or with
3 M forskolin. An additional 6 wells were treated with IBMX
and 30 MCl-dAdo. In the final 15min of incubation, forskolin
was added to 3 of these 6 wells. All remaining wells received no
further additions. Buffer was then carefully aspirated, and cells
were lysed by addition of 0.1%TritonX-100 in 0.1MNaOH (150
l) followed by an equal volume of 0.1% Triton X-100 in 0.1 M
HCl. The neutralized cell lysates were assayed for cAMP con-
tent using a cAMP radioimmunoassay kit per manufacturer’s
instructions for non-acetylated samples.
RESULTS
Adenosine Transporters in Acceleration of the Sperm Flagel-
lar Beat—Our past work suggested that adenosine and related
analogs may enter sperm via equilibrative and concentrative
nucleoside transporters (ENTs and CNTs) to engage a cAMP-
mediated signaling pathway that increases sperm flagellar beat
frequency (10, 11). For the mouse, the Slc28a1–3 genes encode
CNT1–3 (25) and Slc29a1-4 genes encode ENT1–4 (26). Since
integral membrane proteins of sperm are obligatorily produced
during spermatogenesis or spermiogenesis, we applied qRT-
PCR to quantify the relative expression of nucleoside trans-
porter transcripts in adult testis. The results (Fig. 1A) show that
the testis has little or nomRNA for the Slc28a family, withmore
mRNA for the Slc29a genes. The relative abundance of the
prominent Slc29a1 mRNA is 160- and 32-fold greater than
mRNAof Slc29a4 and Slc29a2, the products of the genes for the
other surface membrane ENT transporters (the Slc29a3
encodes ENT3, which is predominantly mitochondrial (27)).
Consequently, our focus turns to Slc29a1, the nucleoside trans-
porter gene that is most highly expressed in the testis.
To test directly for a required role of ENT1 in sperm
responses to adenosine analogs, we used the Slc29a1-null
mouse (16). In the experiments of Fig. 1B, the averaged beat
frequencies of resting sperm from wild-type and Slc29a1-null
mice were 3 Hz. Upon challenge with 25 M Cl-dAdo, the
beat of wild-type sperm accelerated by 2.3 Hz min1 reaching
5.6 Hz at 90 s of stimulus. In comparison, the Slc29a1-null
sperm accelerated by 1.4 Hz min1, reaching 4.3 Hz at 90 s.
Although the adenosine analog increases beat frequency of the
Slc29a1-null sperm, the flagellar waveform is abnormal (see
supplemental videos and Fig. S1). Specifically, we consistently
observe an apparent stiffness of the proximal flagellum so that
the flagellar beat appears to initiate in the principal piece rather
than in the proximal flagellum.We interpret this flagellar wave-
FIGURE 1. Testicular expression of Slc28a and Slc29a, acceleration of
Slc29a1-null sperm by Cl-dAdo. A, relative expression of Slc28a and Slc29a
genes in the testis was determined by quantitative RT-PCR of testicular RNA
with gene-specific primers. PCR products were verified by sequencing, and
predicted product length was verified by agarose gel electrophoresis (lower
panel). B, individual wild-type and Slc29a1/ sperm were perfused for 45 s
with Medium HS, then (at t 	 0) for 90 s with HS containing 25 M Cl-dAdo.
Shown are mean beat frequencies for cells sampled at 60, 0, 30, 60, and 90 s
(n 	 21– 60 cells in three independent experiments). Mean acceleration
determined by regression analysis of the initial 60 s of response.
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form abnormality to be a probable result of a developmental
defect introduced into the flagellum by the absence of the
ENT-1 transporter in spermatogenic cells or in the Sertoli cells
that support them during spermiogenesis. The same develop-
mental defect may explain the diminished ability of the flagel-
lum of mature Slc29a1-null sperm to respond to accelerating
stimuli. We conclude that, although decreased in extent, the
ability of Cl-dAdo to accelerate the beat of Slc29a1-null sperm
is inconsistent with a required role for ENT1.
We also applied a pharmacological approach to examine
the role of Slc29a-family transporters. Nitrobenzylthioinosine
(NBTI) rapidly inhibits both ENT1 and ENT2 at 10 M and
likely also inhibits ENT3 and ENT4 (26). In the experiments of
Fig. 2A, 12.5 M Cl-dAdo accelerated the beat of wild-type
spermby 2.1Hzmin1, reaching 5.1Hz after 90 s of stimulus. In
the presence of 10 M NBTI, Cl-dAdo accelerated the beat by
2.3Hzmin1, reaching 5.4Hz at 90 s. The inability of this broad
spectrum ENT inhibitor to diminish sperm response to
Cl-dAdo suggests that ENT-1 and other Slc29a-family equili-
brative nucleoside transporters are not required for flagellar
response to Cl-dAdo.
Fig. 2B examines possible involvement of the Slc28a family of
concentrative nucleoside transporters in sperm. Because CNTs
are driven by the transmembrane [Na] gradient, we replaced
external Na with N-methyl-D-glucamine (NMDG). Sperm
were perfused with Na-containing HS medium or with
NMDG-substituted (Na-deficient) medium for 1 min, then
challenged with the same medium containing 25 M Cl-dAdo.
The acceleration of the beat (4.4 Hz and 4.2 Hz min1) was
indistinguishable, reaching 8.7 and 8.5Hz after 90 s of stimulus.
A final challenge with 15mMHCO3 produced little or no addi-
tional increase. Because removal of sodium has little impact on
sperm response to Cl-dAdo, we conclude that Slc28a family
(CNT) transporters also are not required.
Adenosine Receptors in Testis and Sperm—With strong indi-
cations that adenosine analog action does not require entry via
cell surface adenosine transporters, we applied pharmacology
to evaluate the alternate hypothesis that analog action involves
cell surface adenosine receptors. Table 1 compares averaged
beat frequencies of sperm bathed (1–5 min) in HS medium
alone, withCl-dAdo, orwith agonists selective for the 3 families
(A1R, A2R, and A3R) of adenosine receptors that have been
defined by pharmacological response and binding profiles (13).
The resting beat frequency (in HS alone) was 3–3.5 Hz, and
increased 2-fold in the presence of Cl-dAdo, consistent with
Figs. 1 and 2. TheA1R-selective agonist CCPA (100M) did not
change the beat frequency significantly, and the A2aR- and
A2bR-selective agonist CGS21680 (40 M) slightly slowed the
beat (to 2.5 Hz). By contrast, with the A3R-selective agonist
Cl-IB-MECA (30 M) the mean beat was 5.9 Hz, indistinguish-
able from that with Cl-dAdo. The related A3R agonist
IB-MECA (100 M) also was effective; however the mean beat
with IB-MECA (5.1 Hz) was marginally slower than with either
Cl-dAdo or Cl-IB-MECA. Fig. 3 shows the concentration
dependence of the extent and time-course of response of the
flagellar beat to Cl-IB-MECA. With 1 to 30 M Cl-IB-MECA,
the beat accelerated linearly for 60–90 s before reaching a sus-
tained, concentration-dependent, elevated rate. The potency of
Cl-IBMECA shown here (EC50 5 M) is consistent with its
FIGURE 2. Cl-dAdo action resists ENT inhibitor NBTI and blockade of CNT
by Na removal. A, individual wild-type sperm were perfused for 60 s with
Medium HS containing 0 or 10 M NBTI, then (at t 	 0) for 90 s with the same
medium fortified with 25 M Cl-dAdo. Shown are mean beat frequencies for
cells sampled 60, 0, 30, 60, and 90 s (n 	 12–27 cells in three independent
experiments). B, individual wild-type sperm were perfused for 60 s with
Medium HS (150 mM Na), or with nominally Na-free HS (0 mM Na). At t 	
0, the perfusing media were fortified with 25 M Cl-dAdo. At t 	 120 s these
media were replaced with medium fortified with 15 mM NaHCO3 or 15 mM
tetraethylammonium bicarbonate. Mean beat frequencies for cells sampled
at t 	 60, 0, 30, 60, 90, 120, and 165 s (n 	 21– 45 cells in three independent
experiments) and acceleration were determined as above.
TABLE 1
Responses to selective adenosine receptor agonists
Populations of wild-type spermwere bathed (2–5min) in HSmedium alone or with
the indicated additions. Shown are mean beat frequencies (n 	 20–97 cells in 2–5
independent experiments).




DMSO (1%) 3.27 
 0.17a 59
Adenosine analog
Cl-dAdo (25 M) 6.32 
 0.51d 71
A1R agonist
CCPA (100 M) 3.65 
 0.18a 62
A2R agonist
CGS21680 (40 M) 2.50 
 0.14b 20
A3R agonist
IB-MECA (100 M) 5.06 
 0.37c 53
Cl-IB-MECA (30 M) 5.87 
 0.53c,d 42
a These groups did not differ (p  0.05).
b–d These groups differed from a and from one another (p  0.05).
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published potency in A3R-mediated responses in mast cells
(28) Subsequent replacement of 30MCl-IBMECAwith 15mM
NaHCO3 did not further increase the sustained rate. The ago-
nist response profiles of Table 1 and Fig. 3 indicate that an A3R
receptormay initiate acceleration of the flagellar beat evoked by
adenosine and its analogs.
The mouse genome has 3 documented isoforms of Adora3.
Adora3i1 and Adora3i2 share no coding regions. The newly-
recognized Adora3i3 shares exons with both Adora3i1 and
Adora3i2, but shares coding exons only with Adora3i1 (Fig.
4A). If an adenosine receptor is required for Cl-dAdo-evoked
acceleration of sperm, then that receptor should be expressed
in their spermatogenic cell precursors. Using primers to
amplify full-length transcripts, PCR reported that only
Adora3i1 and Adora3i2 transcripts are expressed in the mouse
testis (Fig. 4B). Themobility of theAdora3i1 andAdora3i2PCR
products indicated they were the appropriate size, and
sequencing confirmed their identification. Using an approach
similar to that in Fig. 1, we applied qRT-PCR to examine abun-
dance ofAdora1, -2a, -2b, and -3mRNA in the adult testis. Fig.
4C shows that mRNA for Adora3i2 is 13-fold more abundant
than mRNA for Adora3i1, and 250-fold more abundant than
mRNA for Adora1, -2a, and -2b.
Sperm Phenotype of the Adora3 Knock-out Mouse—Antici-
pating use of theAdora3 knock-outmouse to test for a required
role of A3 receptors in sperm, we performed PCR on testes
from Adora3/ mice and from age-matched Adora3/ mice
of the same genetic background. Fig. 5A shows that RNA from
wild-type testis produces Adora3i1 and Adora3i2 PCR prod-
ucts. As expected, the Adora3/ testis lacks the Adora3i1
transcript. Surprisingly, the Adora3i2 transcript was still pres-
ent. Hence, we will refer to these animals as Adora3i1/ or
Adora3i1-null. The second exon of theAdora3 gene is absent in
the Adora3i1/ mouse. The second exon is the only coding
exon in the Adora3i3 transcript, therefore the Adora3i1/
mouse also does not express Adora3i3/.
Using this new insight about the Adora3 knock-out mouse,
we could test specifically whether the Adora3i1 isoform is
required for evoked acceleration. In the experiments of Fig.
5B we challenged Adora3i1/ and Adora3i1/ sperm with
A3R agonists. With 25 M Cl-dAdo, the flagellar beat of
Adora3i1/ sperm accelerated by 1.4 Hz min1, reaching 4.9
Hz at 90 s of stimulus.Adora3i1/ sperm accelerated by 1.9Hz
min1, reaching 5.5 Hz at 90 s. With Cl-IB-MECA (30 M), the
beat ofAdora3i1/ sperm accelerated by 1.0Hzmin1 reaching
4.1 Hz after 90 s, and the beat of Adora3i1/ sperm accelerated
by 1.9 Hz min1 reaching 5.0 Hz at 90 s. The ability of Cl-dAdo
andCl-IB-MECA to accelerate the beat ofAdora3i1-null sperm is
inconsistent with a required role of the Adora3i1. It suggests
instead that the A3Ri2 protein product of Adora3i2 initiates
responses to adenosine analogs.
Coupling of Adenosine Receptors to Gi Proteins in Sperm—
For somatic cells, much past work reports that adenosine A3
receptors activate Gi to decrease production of cAMP (13). If
Gi proteins are required for the accelerating action of adeno-
sine analogs on sperm, then inactivation of Gi/o proteins with
pertussis toxin should block acceleration. Fig. 6 examines
sperm responses after incubation in medium HS alone, or
medium containing pertussis toxin (Ptx), heat-inactivated Ptx,
FIGURE 3. Acceleration of the flagellar beat by A3R agonist Cl-IB-MECA.
Individual wild-type sperm were perfused for 120 s with Medium HS contain-
ing 0 –30 M Cl-IB-MECA as indicated, then for 45 s with HS fortified with 15
mM NaHCO3. Shown are mean beat frequencies for cells sampled at 0, 30, 60,
90, 120, and 165 s (n 	 24 –36 cells in three independent experiments). Mean
acceleration determined by regression analysis of the initial 60 s of response
was 0.08 
 0.05, 2.3 
 0.9, 2.8 
 1.1, and 4.8 
 1.0 Hz min1. Perfusion with 30
M Cl-IB-MECA for 90 s increased beat frequency significantly (p 	 0.021).
FIGURE 4. Adora gene expression in the adult testis. A, organization of the
mouse Adora3 gene, present on chromosome 3: 105673825–105726959.
Approximate scale indicated by scale bar. Numbers at the right indicate exon
useages. B, PCR for full-length Adora3 transcripts in the testis; Adora3i1 (black
arrowhead) and Adora3i2 (white arrowhead) were amplified. C, relative
expression of Adora transcripts in the testis reported by quantitative RT-PCR
of testicular cDNA with isoform-specific primers for Adora1, Adora2a,
Adora2b, Adora3i2, and primer for the conserved coding region of Adora3i1
and Adora3i3. PCR products were confirmed by sequencing and predicted
product length was verified by agarose gel electrophoresis (lower panel).
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or with the inactive B-oligomer of the toxin. Sperm from each
treatment group were challenged with the agonists Cl-dAdo
and Cl-IB-MECA and with NaHCO3. As in work above (Figs.
1–3 and Table 1), for sperm incubated with buffer alone the
beat frequency increased substantially in response to both ago-
nists and to HCO3. Sperm incubated with either heat-inacti-
vated Ptx or B-oligomer showed similar increases. In contrast,
cells incubated with Ptx had significantly diminished responses
to Cl-dAdo and to Cl-IB-MECA, yet responded robustly to the
HCO3 anion that directly activates SACY, the atypical adenylyl
cyclase of sperm (14, 15). These data indicate that Gi is
required for sperm response to the adenosine analog and to an
A3R-selective agonist.
Functional Expression of Adenosine Receptors in Cells Trans-
fected with Adora3i2—We have established that the sperm of
Adora3i1/ mice respond to A3R-selective agonists via a Gi-
coupled mechanism, and that their testes express Adora3i2
mRNA. We sought direct demonstration that Adora3i2 pro-
duces a functional A3R receptor that has not been character-
ized previously. For this purpose, we expressed the cloned
Adora3i2 heterologously in tsA-201 cells, which lack detectable
mRNA for endogenous adenosine receptors (as determined by
PCR; data not shown). Fig. 7 compares the cAMP content of
cells co-transfected either with a RFP-tagged construct con-
taining the full-length Adora3i2 transcript, or mock-trans-
fectedwith a vector containing only an expressionmarker. Both
groups of cells were challenged with medium alone, with Cl-
FIGURE 5. A3R agonists accelerate the beat of wild-type and Adora3i1/
sperm. A, Adora3/ and Adora3/ testis were probed for the presence of
full-length transcripts of Adora3i1 and Adora3i2 (A3i1 and A3i2). B, individual
sperm were perfused for 60 s with Medium HS, then (at t 	 0) for 120 s with HS
containing 25 M Cl-dAdo or 30 M Cl-IB-MECA, then for 60 s with Medium HS
fortified with 15 mM NaHCO3. Shown are mean beat frequencies for sperm of
wild-type (n 	 18 –24 cells in three experiments) and Adora3i1/ mice (n 	
12–30 cells in three experiments), sampled at t 	 60, 0, 30, 60, 90, 120, and
180 s. Mean acceleration determined by regression analysis of the initial 60 s
of response to Cl-dAdo and Cl-IB-MECA. Wild-type and Adora3i1/ sperm
showed no significant difference in beat frequency after 90 s of perfusion with
Cl-dAdo (p 	 0.23), but the beat was slightly slower (p  0.01) for Adora3i1/
than for wild-type sperm after 90 s of perfusion with Cl-IB-MECA.
FIGURE 6. Pertussis toxin blocks acceleration by Cl-dAdo. Wild-type sperm
were treated for 30 min in Medium HS alone (none), or with Ptx (4 g/ml),
heat-inactivated (iPtx; 4 g/ml), or Ptx B-oligomer (B-oligo; 4 g/ml). Popula-
tions of loosely-tethered sperm from each treatment group were bathed for
2–5 min with Medium HS alone, or with HS fortified with Cl-dAdo (25 M),
Cl-IB-MECA (30 M), or NaHCO3 (15 mM). Shown are mean beat frequencies
(n 	 40 – 60 cells in 5 experiments, except n 	 18 –30 cells in three experi-
ments for the B-oligo treatment group). Mean frequencies for untreated con-
trols challenged with Cl-dAdo (6.77 
 0.53 Hz) or Cl-IB-MECA (5.86 
 0.56 Hz)
were significantly higher than for Ptx-treated cells (3.70 
 0.15 and 3.17 

0.17 Hz). Asterisk indicates p  0.001.
FIGURE 7. Adenosine reduces forskolin-evoked cAMP rise in cultured
cells expressing Adora3i2. tsA-201 cells expressing cloned mouse
Adora3i2 tagged with RFP (Adora3i2) or expressing cytosolic GFP alone
(Mock) were treated with medium that was supplemented at (t 	 0) with
either: no additions (None), 30 M Cl-dAdo, 3 M forskolin (FSK), or with 3
M forskolin after addition of 30 M Cl-dAdo at t 	 5 min (Cl-dAdo  FSK).
At t 	 15 min, assays were terminated and cAMP content of the neutral-
ized extracts was determined by radioimmunoassay. Protein content was
determined on assay of parallel cultures. The right axis shows responses
normalized to the mean basal content and the mean content of cells
treated with forskolin alone. The cAMP content of Adora3i2-expressing
cells was reduced significantly (60%) for cells receiving Cl-dAdo prior to
addition of forskolin compared with cells challenged with forskolin alone.
Double asterisk indicates p  0.002.
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dAdo, with forskolin, or with Cl-dAdo then forskolin in the
continued presence of Cl-dAdo. The basal cAMP contents of
mock-transfected controls and Adora3i2-expressing cells were
indistinguishable. This basal content (40 pmol/mg protein)
was unchanged by treatment with Cl-dAdo, confirming an
absence of endogenous Gs-coupled adenosine receptors. For-
skolin-evoked stimulation of endogenous adenylyl cyclase(s)
increased the cAMP content 4-fold for both mock- and
Adora3i2-transfected cells. For mock-transfected cells, the
forskolin-evoked increase in cAMP content was not signifi-
cantly changed by Cl-dAdo. By contrast, for Adora3i2-trans-
fected cells, co-challenge with Cl-dAdo reduced the forsko-
lin-evoked rise in cAMP content by 60% (p 	 0.002). Thus,
Adora3i2 reduces evoked accumulation of cAMP, presum-
ably by coupling to Gi. Functional expression ofAdora3i2 is
demonstrated.
Database Mining for Tissue-selective Expression of Mouse
Adora3i2 and Human ADORA3 Splice Variants—Four pub-
licly available, searchable gene-array databases (29–32) provide
complementary information about the tissue expression pro-
files for the adenosine receptor genes of rat,mouse, and human.
Our searches of these databases (see supplemental Figs. S2–S5)
found indications of highly restricted expression of Adora3i2
in spermatogenic cells of mouse testis, where it likely produces
an A3R2 protein that functions in sperm. A similar prominent
expression of rAdora3 (a paralog of mAdora3i2) was indicated
in rat round spermatids. Interpretation of the data for human
tissue was more complicated, also indicating restricted expres-
sion of ADORA3(s) in testis, but not establishing isoform
identity.
Selective Expression of ADORA3i3 in Human Testis—To
identify the adenosine receptors expressed in human testis we
performed qRT-PCR on human testis RNA using primers spe-
cific for the 3 splice variants ofADORA3 shown in Fig. 8A.With
primers designed to span exons 1–2 of human ADORA3,
ADORA3i3was the predominantADORA3 transcript,8-fold
more abundant than ADORAi2 (Fig. 8B). No expression of
ADORA3i1was detected. The lower panel of Fig. 8B shows that
with primers designed to amplify full-length transcripts, the
PCR products of human testis cDNA report expression only of
transcripts ofADORA3i2 andADORA3i3. It is noteworthy that
ADORA3i3 is orthologous to Adora3i2 in mouse. Thus, the
pattern of expression in the human testis parallels that in the
mouse testis.
At the amino acid level, the A1R, A2aR, and A2bR of rat and
mouse are more closely related to each other than to the human
A1R,A2aR, andA2bR(supplemental Fig. S6). Similarly, themouse
A3i1R is closer in sequence to rat A3R than to human A3Ri2.
Curiously, the rat apparently lacks a testis-specific Adora3 iso-
form. Rat spermatogenic cells express the sameAdora3 transcript
(29) that presumably is expressed in somatic cells.
DISCUSSION
Over the last decade, the targeted-disruption (“knock-out”)
approach has contributed substantially to our understanding of
the signaling processes that operate in sperm. Examples include
the complete loss-of-function phenotypes in the SACY/ (8)
and C2/ (9) mice that provided definitive evidence for
required roles of SACY and the C2 subunit of PKA in the
stimulatory actions of the HCO3 anion on the flagellar beat. In
the work that we now report, absence of the expected loss-of-
function phenotype for sperm of the Slc29a1/ mouse also
has been informative, providing evidence that ENT-1 is not
required for adenosine analogs to speed the flagellar beat.
The nonessential role of ENT-1 does not support our past
proposal (11) that adenosine may act intracellularly following
its entry into spermvia ENTandCNT transporters. This incon-
sistency prompted additional study of the pharmacological
profile of responses to adenosine analogs. The results strongly
suggested that we reconsider involvement of a cell surface A3R
adenosine receptor. The blockade of A3R agonist action on
spermbyPtx provided additional incentive to examine this pos-
sibility. Sensitivity to Ptx is consistent with the known coupling
of A3R and A1R to Gi in some somatic cells (13) and with the
prominent presence of Gi in sperm (33).
Unexpectedly, we found that sperm of the A3R-knock-out
mouse still respond to A3R agonists. This lack of the expected
loss-of-function phenotype also has been informative. Clarifi-
cation arose from demonstration that transcripts of Adora3i1
are absent, but that Adoras3i2 transcripts are still produced in
the knock-out testis. The apparent explanation is that although
the targeting construct for theA3R knock-out replaced the seg-
ment between the initiation codon through the third trans-
membrane domain ofAdora3i1 and part of the intron, the con-
struct terminated in 78.5 kb of genomic DNA that contained
the second exon (21). Thus the upstream promoter region and
first exon of Adora3i2 are unperturbed, and transcription of
FIGURE 8. ADORA3 gene expression in the human testis. A, organization
of the human ADORA3 gene, present on chromosome 1:112025971-
112106597. Approximate scale indicated by scale bar. Numbers at the right
indicate exon useages. B, relative expression of ADORA3 transcripts in the
testis reported by quantitative RT-PCR of testicular RNA with gene-specific
primers. PCR products were confirmed by sequencing, and predicted product
length was verified by agarose gel electrophoresis (lower panel).
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exons 2–7 is not prevented. Therefore, the “A3R-knock-out” is
more accurately the “A3Ri1-knock-out” mouse.
Two lines of indirect evidence suggest that Adora3i2 tran-
scripts in spermatogenic cells produce an A3R that initiates
sperm responses to Cl-dAdo and A3R-selective agonists. First,
we find that Adora3i2 is the predominant Adora family tran-
script in adult wild-type testis. Moreover,Adora3i2 is by far the
most prominent transcript in postmeiotic germ-line cells. Sec-
ond, we show that recombinant Adora3i2 forms functional
Gi-coupled receptors in cultured cells. For now, we lack direct
evidence for the presence and localization of A3Ri2 protein on
the sperm surface.
Some recent work reports immunological evidence of A1R in
sperm and finds that A1R-selective agonist CCPA evokes Ca2
entry into sperm of wild-type, but not A1R-knock-out mice
(34). Although we find that CCCPA does not accelerate the
flagellar beat, we cannot exclude the possibility that it evokes
other A1R-mediated responses. We do find however that
Adora1 transcripts are much less abundant than those of
Adora3i2 in the adult testis, and available gene-array data finds
onlyminimal signals forAdora1 in post-meiotic germ-line cells
of the mouse (31) or rat (29).
If we accept that the accelerating actions of Cl-dAdo and
A3R-selective agonists are initiated by the putative A3Ri2 of
mouse sperm, then we must ask what events couple A3Ri2 to
the cAMP-mediated, SACY- and PKA-requiring pathway that
speeds the flagellar beat. Several reports indicate that in
somatic cells A3Rs engage a signaling cascade involving
ERK1/2. Examples include the human A3R expressed in CHO
cells, where  subunits released from Gi apparently engage
PI3K, Ras, and MEK to phosphorylate ERK1/2 (35, 36). Simi-
larly in mast cells, A3R also couples through Gi3 to engage
ERK1/2 signaling (28). Recently a pertussis toxin-sensitive
phosphorylation of ERK1/2 alsowas observed in sperm (34) but
was attributed to activation of A1Rs.
The presence and possible roles of ERK1/2 in sperm have
been studied by several groups, but remain controversial.
Almog et al. (37) found prominent ERK1/2 immunoreactivity
in the human sperm flagellum and showed that stimulation
withOAGpromoted phosphorylation of ERK1/2 and produced
modest increases in motility. De Lamirande and Gagnon (38)
also found that a transient rise in ERK1/2 activity during capaci-
tating incubations of human sperm. By contrast, Nixon et al. (39)
didnot findERK1/2 immunoreactivity,norobserveanychanges in
motility formouse sperm treatedwith inhibitors ofMAPK signal-
ing. Nixon also noted that no fertility defect was reported for
ERK1/ mice (40). ERK2/ mice are embryonic lethal (41). In
addition, Jha et al. (42) found that inhibitors of ERK1/2 failed to
block the proline-directed Ser/Thr phosphorylation that occurs
during capacitating incubation of mouse sperm.
Past work on both mouse Adora3 and human ADORA3
genes has overlooked an unusual shared feature, both contain a
nested pair of isoforms. Adora3i2 is the host for Adora3i1, and
ADORA3i3 is host for ADORA3i2. The nested Adora3i1 and
ADORA3i2 genes each have 2 exons, contained entirely within
an intron of their host, and are on same strand as their host.
They share no exons with their host, thus could be considered
as separate genes rather than splice variants.
The significance of such nested gene pairs is unclear. Yu et al.
(43) found 340 pairs of nested host-guest gene pairs in the
mouse genome. Of the 158 guests that were potentially
expressed, 2/3 had hosts on opposite strands, only 5 had hosts
with similar functions. For the 74 nested genes for which
expression data were then available, 16 had tissue-specific
expression. Thus, theAdora3i1/i2 (and theADORA3i2/i3) pair
is somewhat unusual in its co-localization on the same strand
and in having a shared, related function. At least one previous
precedent exists for a nested gene pair with these traits. Berse
and Blusztajn (44) found that the Slc18a3 gene for the vesicular
acetylcholine transporter VAChT (which stores acetylcholine)
is nested within the first intron of theChat gene for the choline
acetyltransferase, which synthesizes acetylcholine. For the
Slc18a3/Chat pair, nesting may ensure advantageous co-ex-
pression of functionally-linked proteins. For the Adora3i1/i2
pair, nestingmay be related to the tissue-selective expression of
the Adora3i1 to mast cells, and of Adora3i2 to post-meiotic
germ-line cells of the mouse. The similar architecture of the
human ADORA3i1/ADORA3i3 pair may have a similar role
relating to restricted expression of ADORA3i3 in the human
testis.
The expression ofAdora3i1 in testis found here by PCR (Fig.
4) and reported by Affymetrix gene arrays (supplemental Fig.
S2) is consistent with a previous report of testis expression by
tissue profiling with qRT-PCR using Taqman probes and prim-
ers closely-spaced within exon 2 of Adora3i1 (45). The nesting
of Adora3i1 within Adora3i2 makes it likely that the Taqman
probe also reported production of themore abundantAdora3i2
primary (unspliced) transcript. This interpretation also may
explain the highly testis-restricted expression profile observed
by the Taqman method.
In conclusion, our study of the Slc29a1 andAdora3i1 knock-
out mice did not find definitive loss-of-function sperm pheno-
types. However, our work does strongly indicate that expres-
sion of testicular Adora3i2 and its ortholog ADORA3i3
producesmurine A3Ri2 and humanA3Ri3 receptors that allow
adenosine and its analogs to speed the flagellar beat of sperm.
Our work also suggests that generation of an Adora3i2 knock-
out mouse will provide a valuable tool to define the uncharac-
terized Gi-coupled signaling pathway for the accelerating
action of adenosine analogs, and to determine whether sperm
A3Ri2 has a required role in fertilization. A requirement of
mouse A3Ri2 for male fertility would provide strong incentive
to consider the highly similar human ADORA3i3 as a potential
candidate target for male-directed contraception.
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